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Objective: Vascular endothelial growth factor (VEGF) is believed to play a role in the development of atherosclerosis and has been found to
be increased in hypercholesterolemia. We examined the hypothesis that endothelial VEGF and VEGF receptor-2 (VEGFR-2) expression is
upregulated by hypercholesterolemic low-density lipoprotein (LDL) and, because it could be driven by oxidative stress, we tested whether
vitamin C and E supplementation could modulate it.
Methods: Native LDL were characterized after isolation from adult normal (C-LDL), hypercholesterolemic (HC-LDL) and hyper-
cholesterolemic mini-pigs receiving vitamins C and E (HCV-LDL). VEGF, VEGFR-2, HIF-1a and superoxide anion (O2
) productions were
measured in porcine coronary endothelial cells (ECs) incubated for 48 h with native LDL. The effect of exogenous ascorbic acid and a- or h-
tocopherol was also studied.
Results: HC-LDL, with high cholesterol (Pb0.05) and reduced tocopherol/cholesterol ratio (Pb0.05), increased significantly VEGF and
VEGFR-2 ( pb0.001) in EC, associated with higher O2
 and HIF-1a expression, in comparison with C-LDL and HCV-LDL. The addition of
vitamin C and a- or h-tocopherol to the culture medium prevented the induction of VEGF and VEGFR-2 expression by HC-LDL, both at
mRNA and protein levels.
Conclusions: Our data suggest HC-LDL induce endothelial VEGF and VEGFR-2 overexpression at least by increasing oxidative stress, and
HIF-1a is one of the signaling mechanisms involved. Prevention of VEGF and VEGFR-2 upregulation could help explain the beneficial
effects of vitamins C and E in hypercholesterolemia-induced experimental atherosclerosis.
D 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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Coronary artery disease is a major cause of morbidity and
mortality worldwide. Hypercholesterolemia, a major risk
factor for coronary artery disease, is characterized by
impaired endothelial function of the coronary arteries and
has been used in experimental animals as a surrogate for0008-6363/$ - see front matter D 2004 European Society of Cardiology. Publishe
doi:10.1016/j.cardiores.2004.08.006
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E-mail address: josean@unav.es (J.A. Rodrı´guez).early coronary atherosclerosis. Even in the absence of overt
atherosclerotic changes in the vascular wall, these functional
abnormalities are associated with subtle morphological
alterations, such as increased density of vasa vasorum in
the coronary adventitia [1] and augmented vascular perme-
ability [2]. It has been proposed that these vascular
responses may be mediated by the release of growth factors,
such as vascular endothelial growth factor-A (VEGF) [3].
VEGF, the main factor responsible for angiogenesis and
vascular permeability, is a 45-kDa glycoprotein secreted in
the vascular wall by endothelial cell (EC) and smooth
muscle cells (VSMC). Its expression is regulated mainly by65 (2005) 665–673d by Elsevier B.V. All rights reserved.
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 oxidative stress [4], hypoxia [5] and nitric oxide (NO) [6,7].
The biological effects of VEGF are mediated mainly by two
tyrosine kinase receptors: VEGFR-1 (Flt-1) and VEGFR-2
(flk-1/KDR). Endothelial VEGFR-2 expression is essential
for vasculogenesis, angiogenesis and hematopoiesis [8].
This proangiogenic cytokine has been used in clinical trials
to stimulate collateral vessel formation for the treatment of
ischemic heart disease [9], whereas experimental studies
have shown that VEGF-mediated angiogenesis is not only
necessary but sufficient for atherosclerotic plaque growth
[10].
Hypercholesterolemia is also characterized by increased
oxidative stress and low NO bioavailability, two mecha-
nisms known to contribute to atherosclerotic plaque
development that are also involved in the regulation of
VEGF expression [4,6]. Increased VEGF levels have been
reported in plasma from hypercholesterolemic individuals
[11], in coronary arteries from hypercholesterolemic pigs
[3] and in the vascular wall of apolipoprotein E-deficient
(apoE/) mice [12]. In this context, assuming that VEGF
acting through VEGFR-2 may be one of the factors
responsible for the increased permeability and adventitial
angiogenesis observed in porcine hypercholesterolemia [3],
we hypothesized that native LDL isolated from hyper-
cholesterolemic animals (HC-LDL) could differentially
upregulate either of these genes in porcine coronary
endothelial cells.
Whereas there is still controversy as to the potential role
of antioxidant strategies in cardiovascular disease preven-
tion [13,14], we and others have convincingly shown the
potential for different dietary antioxidants to help prevent
the development and progression of atherosclerosis in
certain experimental models, giving support to this hypoth-
esis [15–17].
Considering that changes in endothelial expression of
VEGF and/or VEGFR-2 induced by HC-LDL could be a
consequence of increased oxidative stress, we examined the
effect of LDL from hypercholesterolemic pigs supple-
mented with vitamins C and E on porcine coronary
endothelial cell cultures. The effect of exogenous addition
of vitamins C and a- or h-tocopherol was also investigated,
to elucidate whether antioxidant mechanisms can fully
account for the effects of vitamin supplementation.2. Methods
2.1. Experimental protocol
A total of 18 male Yucatan miniature pigs (4-months
old; mean weight, 33F2 kg), were procured from our
breeding center and maintained in the animal facilities of
CIFA (Centro de Investigacio´n en Fa´rmaco-Biologı´a
Aplicada) a GLP-accredited center at the University of
Navarra (Pamplona, Spain). The investigation conforms
with the Guide for the Care and Use of LaboratoryAnimals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996) and was
approved by the Animal Research Ethics Committee of
University of Navarra.
Animals were divided into three groups and fed for 12
weeks, using the following dietary formulations: standard
porcine chow (Porcisanders, Sanders, Spain; C, n=6); high-
cholesterol diet (HC, n=6) containing 24.5% animal lard,
4% cholesterol (Roig Farma, Spain) and 1.5% biliar extract
(Roig Farma); and a high-cholesterol diet plus vitamins C
and E (HCV, n=6) given in the same way as HC for 3
weeks, and supplemented thereafter 9 weeks with 1 g
ascorbic acid and 1000 IU d,l-a-tocopherol acetate (Roig
Farma) per animal and day. This antioxidant supplementa-
tion proved to be efficient at preventing eNOS down-
regulation in vivo [16].
2.2. Low-density lipoprotein isolation
Low-density lipoproteins (LDLs) in a density range of
1.019–1.063 g/ml were isolated from porcine plasma by
density gradient ultracentrifugation as described [16].
Isolation of LDL from hypercholesterolemic plasmas
required a second ultracentrifugation, to separate LDL from
VLDL+IDL. EDTA (1 mmol/l, pH 7.4) and butylated-
hydroxytoluene (BHT, 1 Amol/l) were added to prevent
oxidation of LDL throughout the isolation. LDL protein was
determined by Lowry’s method [18], and cholesterol was
measured by standard enzymatic assay. LDL lipid perox-
idation was measured as thiobarbituric acid-reactive sub-
stances (TBARS) [12]. LDL characterization was completed
by electrophoretic mobility on 3% SDS-polyacrylamide gels
(SDS-PAGE) and measurement of tocopherol content. LDLs
were dialyzed overnight against cell culture medium
(10,000 MWCO Slyde-A-Lyzer, Pierce, USA) before
addition to cell cultures.
2.3. Cell culture
Coronary arteries from untreated pigs (n=15) were used
to obtain normal EC cultures as previously described [16].
Experiments were carried out on subcultured passage 2 to 3
cells, after reaching confluency and 48 h of adaptation to
serum-free endothelial medium. a-Tocopherol was from
Merck, ascorbic acid was from Sigma, h-tocopherol was
generously provided by Dr. Christine Gartner (Cognis,
Germany); all the other cell culture reagents were from
GIBCO (Invitrogen SA, Spain).
2.4. RNA isolation and real-time quantitative RT-PCR
Total RNA was extracted from cells with TRIzol
(Invitrogen) and reverse transcribed with oligo(dT) pri-
mers with M-MLV reverse transcriptase (Invitrogen), in
the presence of SuperRNase In (Ambion, USA). About
300 ng reverse-transcribed RNA was primed with
J.A. Rodrı´guez et al. / Cardiovascular Research 65 (2005) 665–673 667
 at U
niversidad de N
avarra on M
ay 24, 2012
http://cardiovascres.oxfordjournals.org/
D
ow
nloaded from
 oligonucleotides specific for VEGF (5V-GAGACCCTGG-
TGGACATC-3V and 5V-TTTCTTTGGTCTGCATTC-3V),
VEGFR-2 (5V-GACTGTGGCGAAGTGTTTTTGA–3V
and 5V-GTGCAGGGGAGGGTTGGCGTAG-3V) and h-
actin (5V-GTGCGGGACATCAAGGAGAA-3V and 5V-
AGGAAGGAGGGCTGGAAGAG-3V). Real-time PCR
was performed as described previously (95 8C for 10 min
and run for 40 cycles at 95 8C for 15 s and 60 8C for 1 min)
with SYBR Green PCR Master Mix (Applied Biosystems,
Spain) on the ABI PRISM 5700 Detection System (Applied
Biosystems) [12]. Potential genomic DNA contamination
was excluded by using intron-encompassing primers. All
samples were assayed in triplicate and normalized based on
their h-actin content.
2.5. Protein extraction, electrophoresis and Western blotting
Protein from cell lisates was extracted after RNA
isolation, following TRIzol manufacturer’s instructions.
VEGF and HIF-1a were quantified by Western blotting:
conditioned medium or endothelial cell homogenates (10 Ag
total protein) were subjected to 12% SDS-PAGE, electro-
blotted onto nitrocellulose membranes and probed with
anti-VEGF (1:1000; sc7269, Santa Cruz Biotechnologies,
USA) or anti-HIF-1a (1:1000; sc10790, Santa Cruz
Biotechnologies), followed by a peroxidase-linked sheep
anti-mouse or donkey anti-rabbit IgG (1:5000; Amersham
Biosciences, Spain). Blots were developed by enhanced
chemiluminescence according to the manufacturer’s instruc-
tions (ECL, Amersham Biosciences). VEGFR-2 expression
in cell lysates was similarly assessed, subjected to 6% SDS-
PAGE, probed with anti-VEGFR-2 (1:1000; sc6251, Santa
Cruz Biotechnologies) and developed by enhanced chem-
iluminescence (ECL Plus, Amersham Biosciences). Even
loading was verified by Ponceau red staining.
2.6. Endothelial cell migration assay
This assay was performed in 24-well transwells (5-Am
pore; Corning, Spain) as described [19]. Briefly, 40,000 ECs
resuspended in 100 Al DMEM were seeded into the upper
chamber, and the lower chamber was filled with 600 Al
conditioned medium from native LDL-treated ECs. TheseTable 1
Cholesterol and tocopherol content in plasma and LDL
Group Plasma LDL
Total cholesterol
(mM)
Tocopherol
(AM)
Amol cholesterol/mg
protein
C 1.6F0.1 1.9F0.9 4.16F0.81
HC 5.9F1.5a 1.8F0.5 8.58F1.34b
HCV 6.3F2.1a 15.9F1.9a,c 12.99F1.34b,d
a Statistical significant difference from C, ( Pb0.01).
b Statistical significant difference from C, ( Pb0.05).
c Statistical significant difference between HC and HCV, ( Pb0.01).
d Statistical significant difference between HC and HCV, ( Pb0.05).chambers were incubated for 6 h at 37 8C with 5% CO2 to
allow cells to migrate through the membranes. The non-
migrated cells were scraped from the upper surface of the
membrane with cotton swabs. After a rinse with phosphate-
buffered saline, the membrane was stained with Diff-Quick
Solution (Dade Behring). Five representative fields in each
well were counted under the microscope at 200 magnifi-
cation to determine the number of migrated cells.
2.7. Measurement of superoxide radical (O2
) formation
O2
 production by endothelial cells was measured by
lucigenin-enhanced (5 AM) chemiluminescence, using a 96-
well microplate luminometer (Luminoscan Ascent, Thermo
Labsystems, Finland). Briefly, confluent EC cultures in
serum-free medium were treated with native LDL for 48 h at
37 8C. After washing, EC were incubated in HEPES-
modified Krebs buffer (pH 7.4) containing NADPH (100
AM) for 30 min, and dark-adapted lucigenin (5 AM) was
added into the wells just before reading. Light emission was
recorded and expressed as mean relative light units/s (RLU/
s) over 30 min. The specificity of O2
 thus measured was
confirmed by adding superoxide dismutase (1000 units/ml).
Each experiment was performed at least in triplicate.
2.8. Statistical methods
Data are presented as meanFstandard deviation. Analy-
sis of variance (ANOVA) or Kruskal–Wallis test was
applied to assess differences between treatment groups.
After a significant ANOVA or Kruskal–Wallis, comparisons
were made with Bonferroni post hoc or Mann–Whitney test,
respectively. A value of pb0.05 was accepted as statistically
significant.3. Results
3.1. LDL characterization
Analysis of LDL from the different experimental groups
showed that HC-LDL lipid load was significantly increased
(Pb0.05) in comparison with C-LDL, being HCV-LDLnmol tocopherol/Amol
cholesterol
nmol tocopherol/mg
protein
AM MDA/mg
protein
1.08F0.16 4.50F1.99 0.82F0.19
0.50F0.09b 4.29F2.13 0.88F0.37
1.12F0.09 14.53F3.57a 0.26F0.15a,c
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 even higher (Pb0.05; Table 1). Vitamin E content of LDL,
expressed as tocopherol/protein ratio, was similar in C and
HC groups while it was significantly higher in HCV
( pb0.01), as expected from the observed plasmatic levels
of tocopherol. Nevertheless, LDL from hypercholesterole-
mic animals exhibited a significantly decreased tocopherol/
cholesterol ratio ( pb0.05), as compared with C and HCV
groups (Table 1).
As shown in Fig. 1, changes in lipid composition affected
LDL density and size. LDL from hypercholesterolemic pigs
migrated higher than controls in the density gradient after
plasma ultracentrifugation (Fig. 1), indicating lower density.
Native LDL from different groups also exhibited different
electrophoretic mobilities: HC- and HCV-LDL migrated
more slowly than C-LDL in the 3% SDS-polyacrylamide
gels (Fig. 1).
3.2. Effect of native LDL on VEGF and VEGFR-2
expression
We consistently observed that incubation of normal
porcine coronary EC in the presence of 100 Ag/ml C-LDL
for 48 h did not modify cellular VEGF expression.
However, as shown in Fig. 2A, the same concentration of
HC-LDL induced a significant increase of endothelial
VEGF mRNA ( pb0.001), which paralleled a higher VEGF
protein content in the cell lysates and culture supernatants
( pb0.001, Fig. 2 B and C). Interestingly, conditioned
medium from HC-LDL-treated ECs significantly enhanced
endothelial cell migration in vitro ( pb0.05, Fig 3).
Because VEGFR-2 mediates VEGF angiogenic activity,
we further analyzed the endothelial VEGFR-2 expression inFig. 1. Characterization of LDL from the different experimental groups. Upper pan
Coomassie blue and Sudan black-stained plasmas from control (C), hypercholest
Arrows indicate position of LDL band. Lower panel: LDL electrophoretic mobility
be used as internal control. LDL from hypercholesterolemic pigs showed lower dthe same cultures. As expected, incubation of porcine
coronary ECs with HC-LDL increased significantly
VEGFR-2 mRNA, as compared with either nonstimulated
or C-LDL-treated cells ( pb0.001; Fig. 4A). A significantly
higher VEGFR-2 protein content could also be demonstra-
ted in cell lysates ( pb0.001; Fig. 4B).
HCV-LDL, even when it carried more cholesterol than
HC-LDL, behaved like C-LDL and did not modify
endothelial VEGF and VEGFR-2 expression, both at
mRNA and protein level (Figs. 2 and 4). Moreover,
chemotactic activity of conditioned medium from HCV-
LDL-treated ECs was similar to the one from C-LDL-
treated cells (Fig. 3).
3.3. Effect of native LDL on endothelial O2
 production and
HIF-1a expression
The HC-LDL-increased endothelial VEGF expression
and previous reports describing VEGF induction by
oxidative stress [4] led us to study the effect of LDL on
ECs superoxide anion production. In marked contrast with
C- and HCV-LDL, HC-LDL induced a significant increase
in endothelial O2
 generation ( pb0.05), as detected by
lucigenin chemiluminescence (Fig. 5A). O2
 production in
ECs treated with C- and HCV-LDL did not differ from cells
maintained in the absence of LDL.
Based on the recently reported link between NADPH
oxidase, HIF-1a, VEGF and angiogenesis in atheroma [20],
we also measured endothelial HIF-1a expression. HC-LDL-
treated ECs showed increased expression of HIF-1a protein
( pb0.05), while C- and HCV-LDL-treated cells exhibited
expression levels similar to basal (Fig. 5B).el: relative lipoprotein densities after density gradient ultracentrifugation of
erolemic (HC) or vitamin-supplemented hypercholesterolemic pigs (HCV).
in 3% polyacrylamide gel. A C-LDL sample (*) was included in each gel to
ensity and migrated slower than the control ones.
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Fig. 3. Effect of native LDL on endothelial chemotaxis. As described in
Methods, conditioned medium from coronary endothelial cells incubated
for 48 h with 100 Ag(prot)/ml native LDL from control (C-LDL),
hypercholesterolemic (HC-LDL) or vitamin-supplemented hypercholeste-
rolemic pigs (HCV-LDL) was placed in the bottom chambers. After 6-h
incubation, the number of migrated cells was higher in the wells with HC-
LDL supernatants. Bars show the meanFS.D. for five independent
experiments. Statistically significant differences from basal are marked as
* ( Pb0.05), and from HC-LDL as y ( Pb0.05).
Fig. 4. Effect of native LDL on endothelial VEGFR-2 expression. Coronary
endothelial cells were incubated for 48 h with 100 Ag(prot)/ml native LDL
from control (C-LDL), hypercholesterolemic (HC-LDL) or vitamin-
supplemented hypercholesterolemic pigs (HCV-LDL). (A) VEGFR-2
mRNA expression, assessed by RT-qPCR and corrected by h-actin mRNA
content, reported as percentage increase with respect to untreated cells
(basal). (B) VEGFR-2 protein in cell homogenates was assessed by Western
blot and reported as percentage increase with respect to untreated cells
(basal). HC-LDL selectively induced VEGFR-2 mRNA and protein. Bars
show the meanFS.D. for 10 independent experiments. Statistically
significant differences from basal are marked as *** ( Pb0.001), and from
HC-LDL as yy ( Pb0.01).
Fig. 2. Effect of native LDL on endothelial VEGF expression. Coronary
endothelial cells were incubated for 48 h with 100 Ag(prot)/ml native
LDL from control (C-LDL), hypercholesterolemic (HC-LDL) or vitamin-
supplemented hypercholesterolemic pigs (HCV-LDL). (A) VEGF mRNA
expression, assessed by RT-qPCR and corrected by h-actin mRNA
content, reported as percentage increase with respect to untreated cells
(basal). VEGF protein, assessed by Western blot in cell homogenates (B)
and conditioned culture medium (C), reported as percentage increase
with respect to untreated cells. HC-LDL selectively induced VEGF
mRNA and protein. Bars show the meanFS.D. for 10 independent
experiments. Statistically significant differences from basal are marked as
*** ( Pb0.001), and from HC-LDL as yyy ( Pb0.001).
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 3.4. VEGF and VEGFR-2 expression after addition of
vitamins C and E
After observing that LDL from hypercholesterolemic
pigs supplemented with vitamins C and E did not increase
endothelial VEGF and VEGFR-2 expression, and because
VEGF could be induced by oxidative stress, we further
studied the effect of HC-LDL on ECs incubated with 15 AM
a-tocopherol (similar to the plasmatic concentration
observed in vitamin-supplemented pigs) and an equimolar
amount of ascorbic acid.
The combination of ascorbic acid and a-tocopherol
blocked the induction of VEGF and VEGFR-2 expression
Fig. 5. Effect of native LDL on endothelial O2
 synthesis and HIF-1a
expression. Coronary endothelial cells were incubated for 48 h with 100
Ag(prot)/ml native LDL from control (C-LDL), hypercholesterolemic (HC-
LDL) or vitamin-supplemented hypercholesterolemic pigs (HCV-LDL).
(A) O2
 production, assessed by lucigenin chemiluminescence, reported as
relative light units/s (RLU/s). Bars show the meanFS.D. for nine
independent experiments. (B) HIF-1a protein in cell homogenates was
assessed by Western blot and reported as percentage increase with respect
to untreated cells (basal). Bars show the meanFS.D. for three independent
experiments. Statistically significant differences from basal are marked as
* ( Pb0.05), and from HC-LDL as y ( Pb0.05).
Fig. 6. Effect of vitamins C and E on endothelial VEGF expression.
Coronary endothelial cells were incubated for 48 h with 100 Ag(prot)/ml
HC-LDL in the presence of ascorbic acid (15 AM)+h-tocopherol (15 AM;
CE) or ascorbic acid (15 AM)+a-tocopherol (15 AM; ChE). (A) mRNA
expression, assessed by RT-qPCR and corrected by h-actin mRNA content,
reported as percentage increase with respect to untreated cells (basal).
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 by HC-LDL in porcine coronary ECs, both at mRNA and
protein level (Figs. 6 and 7). Similarly, ascorbic acid and h-
tocopherol also completely prevented VEGF and VEGFR-2
overexpression in HC-LDL-treated EC. Addition of ascor-
bic acid and a- or h-tocopherol per se, in the absence of
LDL, did not modify endothelial VEGF or VEGFR-2
expression (Figs. 6 and 7).VEGF protein, assessed by Western blot in cell homogenates (B) and
conditioned culture medium (C), reported as percentage increase with
respect to untreated cells. The combination of ascorbic acid and a- or h-
tocopherol prevented HC-LDL-induced VEGF overexpression. Bars show
the meanFS.D. for five independent experiments. Statistically significant
differences from basal are marked as *** ( Pb0.001), and from HC-LDL as
y ( Pb0.05), yy ( Pb0.01) or yyy ( Pb0.001).4. Discussion
The present study is the first to show that native LDL
isolated from hypercholesterolemic animals significantlyupregulated VEGF and VEGFR-2 expression in coronary
EC in vitro, associated with higher O2
 production and HIF-
1a expression, whereas LDL from hypercholesterolemic
pigs treated with vitamins C and E did not show such a
stimulatory effect. Moreover, exogenous addition of vita-
mins C and E to the culture medium completely prevented
VEGF induction by HC-LDL, further suggesting an
oxidative stress-mediated mechanism.
VEGF has a dual role in vascular homeostasis: it is not
only the principal agent responsible for angiogenesis,
vascular permeability and maintenance of endothelial
Fig. 7. Vitamin C and E effect on endothelial VEGFR-2 expression.
Coronary endothelial cells were incubated for 48 h with 100 Ag(prot)/ml
HC-LDL in the presence of ascorbic acid (15 AM)+h-tocopherol (15 AM;
CE) or ascorbic acid (15 AM)+a-tocopherol (15 AM; ChE). (A) VEGFR-2
mRNA expression, assessed by RT-qPCR and corrected by h-actin mRNA
content, reported as percentage increase with respect to untreated cells
(basal). (B) VEGFR-2 protein in cell homogenates was assessed by Western
blot and reported as percentage increase with respect to untreated cells. The
combination of ascorbic acid and a- or h-tocopherol prevented HC-LDL-
induced VEGFR-2 overexpression. Bars show the meanFS.D. for five
independent experiments. Statistically significant differences from basal are
marked as *** ( Pb0.001), and from HC-LDL as yyy ( Pb0.001).
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 integrity but it also favors the progression and growth
of the atherosclerotic plaque [21]. We have previously
shown VEGF and VEGFR-2 overexpression in the aorta of
apoE/ mice [12], a well-established model of athero-
sclerosis showing high cholesterol concentration and
increased lipid peroxidation [22], that could be prevented
by vitamins C and E [12].
These observations led us to investigate the effect of
hypercholesterolemia on endothelial VEGF expression; for
this purpose, we incubated porcine coronary EC with native
LDL isolated from hypercholesterolemic mini-pigs. We
have previously shown in this animal model of hyper-
cholesterolemia multiple manifestations of the vascular
inflammatory process such as endothelial dysfunction,
reduced endothelial eNOS expression, with increased
vascular PAI-1 and MMP-1, that can be prevented or
restored by vitamin C and E supplementation [16,17,23].
Aside from potential differences in lipid composition, HC-
LDL distinguished from C-LDL mainly in their higher lipid
load, a lower tocopherol/cholesterol ratio and reduced
electrophoretic mobility. HC-LDL markedly increased
endothelial VEGF expression, both at mRNA and at protein
level, accompanied by a higher chemotactic activity of thecell supernatants, in contrast with C-LDL that did not induce
significant changes with respect to baseline conditions. In
addition, HC-LDL also induced a marked increase in
endothelial VEGFR-2, the major mediator of physiological
and pathological effects of VEGF on ECs, at mRNA and
protein levels, a novel finding not previously described. RT-
PCR for measuring VEGF mRNA expression did not allow
us to distinguish between the different VEGF isoforms (it
amplifies a sequence from exon 3 to 5), but protein changes
were evident in the culture medium and in cellular
homogenates, reflecting an increase in secreted isoforms
as well as in the extracellular matrix-binding ones. Besides
an intense band at 25 kDa, protein homogenates from HC-
LDL-treated EC showed a higher band that could corre-
spond to a heparin-binding isoform induced by the treat-
ment, although an artifact resulting from the increased
amount of VEGF cannot be discarded. Our results confirm
previous reports showing ox-LDL upregulation of VEGF
expression in human coronary artery endothelial cells [24],
although LDL modification by physiological oxidation is
not directly comparable to that obtained in vitro with
CuSO4.
Upregulation of VEGF and VEGFR-2 in the vessel wall
could account for the increased vascular permeability [2]
and enhanced vasa vasorum neovascularization observed in
hypercholesterolemia [1]. Although VEGF upregulation
could constitute a vascular homeostatic mechanism for
compensating endothelial dysfunction [25], sustained vas-
cular VEGF and VEGFR-2 overexpression could contribute
to the atherosclerotic process by favoring lipoprotein
infiltration through increased vascular permeability [2],
recruiting and/or activating monocytes in early atheroscle-
rosis [26] and inducing angiogenesis in advanced lesions
[21]. This hypothesis is further supported by the antiathero-
sclerotic effect of the angiogenesis inhibitors endostatin and
TNP-470 in the apoE/ mouse [27], and recent reports
demonstrating oxidative stress caused by p22phox over-
expression induces vascular expression of VEGF, associated
with angiogenesis and plaque progression [20].
Although the mechanism by which hypercholesterolemia
may induce VEGF upregulation in the vessel wall remains
unclear, among the possible pathophysiological stimuli are
hypoxia [3], oxidative stress [4] and low NO bioavailability
[6]. In our in vitro model, we have found VEGF over-
expression to be associated with augmented O2
 synthesis
that could be leading to increased oxidative stress and
higher levels of HIF-1a capable of inducing VEGF gene
transcription. Increased HIF-1a does not reflect necessarily
the existence of a hypoxic condition, difficult to explain as a
result of HC-LDL treatment, but it could rather be part of
the cellular response to the increased oxidative stress [20].
On the other hand, increased VEGF by itself could be
enough to upregulate VEGFR-2 expression, as previously
described [28]. Therefore, VEGFR-2 augmentation would
be conceivable subsequent to VEGF induction by increased
oxidative stress. However, further studies are required,
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 analyzing the balance between antioxidant (i.e., superoxide
dismutase, catalase and glutathione peroxidase) and proox-
idant genes (i.e., NADPH oxidase, xanthine oxidase), in
order to properly characterize the details of this proposed
mechanism.
Considering that increased reactive oxygen species,
associated with hypercholesterolemia, could be at least
one of the mechanisms responsible for the observed VEGF
increase, we studied the effect of native LDL isolated from
hypercholesterolemic mini-pigs treated with vitamins C and
E. In spite of their relative similarity to HC-LDL, in terms of
lipid load and electrophoretic mobility, HCV-LDL did not
increase VEGF and VEGFR-2 either at mRNA or protein
levels, following a pattern similar to C-LDL. The fact that
HCV-LDL did not induced endothelial O2
 synthesis or
HIF-1a protein could be the most likely explanation.
However, the increased tocopherol/cholesterol and toco-
pherol/protein ratios exhibited by HCV-LDL, explaining
their lower degree of lipid peroxidation, also suggest they
can stand unmodified in the cellular environment for a
longer time because of a lower susceptibility to endothelial
oxidative modifications, thus avoiding VEGF upregulation
due to a direct effect of oxidized LDL. Because changes in
LDL lipid composition and/or physical characteristics could
also be responsible for the absence of induction, we also
studied the effect of treating ECs with vitamin C and a-
tocopherol before incubating with HC-LDL. Vitamin C
allows a-tocopherol regeneration from a-tocopheroxy
radical, hence preventing vitamin E prooxidant activity
and tocopherol-mediated peroxidation [29]. The fact that
ascorbic acid and a-tocopherol supplementation completely
prevented the effect of HC-LDL on VEGF and VEGFR-2
expression further supports our hypothesis.
Nevertheless, it can be speculated that the observed effect
of vitamins C and E could not only be related to their
antioxidant properties but also to the PKC inhibitory activity
of a-tocopherol. The combination of ascorbic acid and h-
tocopherol, an equally strong antioxidant in comparison to
a-tocopherol but lacking other biological properties present
in a-tocopherol (protein kinase C inhibitory and antiproli-
ferative activities) [30], was equally effective at preventing
VEGF and VEGFR-2 overexpression, suggesting that the
reduction of oxidative stress is a crucial mechanism
involved.
In conclusion, we demonstrate that hypercholesterolemic
LDL induces endothelial expression of VEGF and VEGFR-
2, and suggest that increased oxidative stress may be the
main mechanism involved. It is tempting to speculate that
this overexpression could be part of a vascular inflammatory
process, thus favoring the development of atherosclerosis by
facilitating lipoprotein infiltration and monocyte recruit-
ment. However, further studies of the precise pathophysio-
logical effects of vascular VEGF and VEGFR-2
upregulation in hypercholesterolemia, and its pharmacolog-
ical modulation, are required to define its relationship with
the atherosclerotic process.Acknowledgements
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